Relaxin-family peptide and receptor systems in brain: Insights from recent anatomical and functional studies

Advances in Experimental Medicine and Biology

Volumn 612, Issue , 2007, Pages 119-137

  Ma, Sherie ^a   Gundlach, Andrew L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 135; G PROTEIN COUPLED RECEPTOR 142; INSULIN; INSULIN LIKE PEPTIDE 3; INSULIN LIKE PEPTIDE 4; INSULIN LIKE PEPTIDE 5; INSULIN LIKE PEPTIDE 6; LGR7; LGR8; OXYTOCIN; RELAXIN; RELAXIN 2; RELAXIN 3; RELAXIN LIKE FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; UNCLASSIFIED DRUG; VASOPRESSIN; LEYDIG INSULIN LIKE PROTEIN; LEYDIG INSULIN-LIKE PROTEIN; PROTEIN; RECEPTOR; RELAXIN RECEPTORS; RLN3 PROTEIN, HUMAN;

ADRENAL GLAND; BINDING AFFINITY; BINDING SITE; BIOSYNTHESIS; BRAIN; CORPUS LUTEUM; HEMODYNAMICS; HUMAN; HYPOTHALAMUS; LEARNING; MEMORY; NERVE CELL; NEUROENDOCRINE SYSTEM; NONHUMAN; OXYTOCIN RELEASE; PONS ANGLE; PREGNANCY; PRIORITY JOURNAL; PROSTATE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; STRESS; STRUCTURE ACTIVITY RELATION; TESTIS DESCENT; THYMUS; VASOPRESSIN RELEASE; ANIMAL; BRAIN LEVEL; CYTOLOGY; FEMALE; GENETICS; MALE; METABOLISM; MOLECULAR EVOLUTION; MOUSE; PHYSIOLOGY; RAT;

MAMMALIA; PRIMATES;

ANIMALS; BRAIN; BRAIN CHEMISTRY; EVOLUTION, MOLECULAR; FEMALE; HUMANS; INSULIN; MALE; MICE; PREGNANCY; PROTEINS; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RELAXIN;

EID: 38749090956     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74672-2_9     Document Type: Review

References (122)

1. Hisaw FL. Experimental relaxation of the pubic ligament of the guinea pig. Proc Soc Exp Biol Med 1926; 23:661-663.
2. Adham IM, Agoulnik AI. Insulin-like 3 signalling in testicular descent. Int J Androl 2004; 27:257-265.
3. Chassin D, Laurent A, Janneau JL et al. Cloning of a new member of the insulin gene superfamily (INSL4) expressed in human placenta. Genomics 1995; 29:465-470.
4. Conklin D, Lofton-Day CE, Haldeman BA et al. Identification of INSL5, a new member of the insulin superfamily. Genomics 1999; 60:50-56.
5. Hsu SY. Cloning of two novel mammalian paralogs of relaxin/insulin family proteins and their expression in testis and kidney. Mol Endocrinol 1999; 13:2163-2174.
6. Lok S, Johnston DS, Conklin D et al. Identification of INSL6, a new member of the insidin family that is expressed in the testis of the human and rat. Biol Reprod 2000; 62:1593-1599.
7. Kasik J, Muglia L, Stephan DA et al. Identification, chromosomal mapping and partial characterization of mouse InsI6: A new member of the insulin family. Endocrinology 2000; 141:458-461.
8. Bathgate RAD, Samuel CS, Burazin TCD et al. Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family. J Biol Chem 2002; 277:1148-1157.
9. Bathgate RAD, Hsueh AJ, Sherwood OD. Physiology and molecular biology of the relaxin peptide family. In: Neill JD, ed. Knobil and Neill's Physiology of Reproduction. New York: Academic Press, 2006:701-790.
10. Wilkinson TN, Speed TP, Tregear GW et al. Evolution of the relaxin-like peptide family. BMC Evol Biol 2005:5:14.
11. Adham IM, Burkhardt E, Benahmed M et al. Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J Biol Chem 1993; 268:26668-26672.
12. Pusch W, Balvers M, Ivell R. Molecular cloning and expression of the relaxin-likc factor from the mouse testis. Endocrinology 1996; 137:3009-3013.
13. Burkhardt E, Adham IM, Brosig B et al. Structural organization of the porcine and human genes coding for a Leydig cell-specific insulin-like peptide (LEY I-L) and chromosomal localization of the human gene (INSL3). Genomics 1994; 20:13-19.
14. Koskimies P, Spiess AN, Lahti P et al. The mouse relaxin-like factor gene and its promoter are located within the 3′ region of the JAK3 genomic sequence. FEBS Lett 1997; 419:186-190.
15. Zimmermann S, Schottler P, Engel W et al. Mouse Leydig insulin-like (Ley I-L) gene: Structure and expression during testis and ovary development. Mol Reprod Dev 1997; 47:30-38.
16. Spiess AN, Balvers M, Tena-Sempere M et al. Structure and expression of the rat relaxin-like factor (RLF) gene. Mol Reprod Dev 1999; 54:319-325.
17. Bullesbach EE, Gowan LK, Schwabe C et al. Isolation, purification and the sequence of relaxin from spiny dogfish (Squalus acanthias). Eur J Biochem 1986; 161:335-341.
18. Lu C, Walker WH, Sun J et al. Insulin-like peptide 6: Characterization of secretory status and posttranslational modifications. Endocrinology 2006; 147:5611-5623.
19. Liu C, Kuei C, Sutton S et al. INSL5 is a high affinity specific agonist for GPCR142 (GPRIOO). J Biol Chem 2005; 280:292-300.
20. Dun SL, Brailoiu E, Wang Y et al. Insulin-like peptide 5: Expression in the mouse brain and mobilization of calcium. Endocrinology 2006; 147:3243-3248.
21. Burazin TCD, Bathgate RAD, Macris M et al. Restricted, but abimdant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain. J Neurochem 2002; 82:1553-1557.
22. Liu C, Eriste E, Sutton S et al. Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein coupled receptor GPCR135. J Biol Chem 2003; 278:50754-50764.
23. Hsu SY. New insights into the evolution of the relaxin-LGR signaling system. Trends Endocrinol Metab 2003; 14:303-309.
24. Hudson P, Haley J, John M et al. Structure of a genomic clone encoding biologically active human relaxin. Nature 1983; 301:628-631.
25. Crawford RJ, Hudson P, Shine J et al. Two human relaxin genes are on chromosome 9. EMBO J 1984; 3:2341-2345.
26. Garibay-Tupas JL, Csiszar K, Fox M et al. Analysis of the 5′-upstream regions of the human relaxin H1 and H2 genes and their chromosomal localization on chromosome 9p24.1 by radiation hybrid and breakpoint mapping. J Mol Endocrinol 1999; 23:355-365.
27. Bathgate RAD, Scott D, Chung SWL et al. Searching the human genome database for novel relaxin-like peptides. Letts Pept Sci 2002; 8:129-132.
28. Fowler KJ, Clouston WM, Fournier RE et al. The relaxin gene is located on chromosome 19 in the mouse. FEBS Lett 1991; 292:183-186.
29. Schwabe C, Bullesbach EE. Relaxin: Structures, functions, promises and nonevolution. FASEB J 1994; 8:1152-1160.
30. Bryant-Greenwood GD, Schwabe C. Human relaxins: Chemistry and biology. Endocr Rev 1994; 15:5-26.
31. Gast MJ. Studies of luteal generation and processing of the high molecular weight relaxin precursor. Ann N Y Acad Sci 1982; 380:111-125.
32. Gast MJ. Characterization of preprorelaxin by tryptic digestion and inhibition of its conversion to prorelaxin by amino acid analogs. J Biol Chem 1983; 258:9001-9004.
33. Hudson P, Haley J, Cronk M et al. Molecular cloning and characterization of cDNA sequences coding for rat relaxin. Nature 1981; 291:127-131.
34. Hsu SY, Nakabayashi K, Nishi S et al. Activation of orphan receptors by the hormone relaxin. Science 2002; 295:671-674.
35. Tregcar GW, Ivell R, Bathgate RAD et al. Proceedings of the Third International Conference on Relaxin and Related Peptides. Dordrecht: Kluwer Academic Publishers; 2001.
36. Bartsch O, Bartlick B, Ivell R. Relaxin signalling links tyrosine phosphorylation to phosphodiesterase and adenylyl cyclase activity. Mol Hum Reprod 2001; 7:799-809.
37. Palejwala S, Stein D, Wojtczuk A et al. Demonstration of a relaxin receptor and relaxin-stimulated tyrosine phosphorylation in human lower uterine segment fibroblasts. Endocrinology 1998; 139:1208-1212.
38. Hsu SY, Kudo M, Chen T et al. The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol Endocrinol 2000; 14:1257-1271.
39. Sudo S, Kumagai J, Nishi S et al. H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J Biol Chem 2003; 278:7855-7862.
40. Hsu SY, Nakabayashi K, Nishi S et al. Relaxin signaling in reproductive tissues. Mol Cell Endocrinol 2003; 202:165-170.
41. Bullesbach EE, Schwabe C. LGR8 signal activation by the relaxin-like factor. J Biol Chem 2005; 280:14586-14590.
42. Halls ML, Bathgate RA, Summers RJ. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms. Mol Pharmacol 2006; 70:214-226.
43. Kumagai J, Hsu SY, Matsumi H et al. INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J Biol Chem 2002; 277:31283-31286.
44. Kawamura K, Kumagai J, Sudo S et al. Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc Natl Acad Sci USA 2004; 101:7323-7328.
45. Anand-Ivell RJ, Relan V, Balvers M et al. Expression of the insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis. Biol Reprod 2006; 74:945-953.
46. Zimmermann S, Steding G, Emmen JM et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 1999; 13:681-691.
47. Feng S, Cortessis VK, Hwang A et al. Mutation analysis of INSL3 and GREAT/LGR8 genes in familial cryptorchidism. Urology 2004; 64:1032-1036.
48. Gorlov IP, Kamat A, Bogatcheva NV et al. Mutations of the GREAT gene cause cryptorchidism. Hum Mol Genet 2002; 11:2309-2318.
49. Shen PJ, Fu P, Phelan KD et al. Restricted expression of LGR8 in intralaminar thalamic nuclei of rat brain suggests a role in sensorimotor systems. Ann N Y Acad Sci 2005; 1041:510-515.
50. Sedaghat K, Shen P-J, Allbutt H et al. Localization, lesion and functional studies of the INSL3 receptor, LGR8, in brain: Further evidence for role in sensorimotor pathways. Soc Neurosci Abstr 2005: P725.711.
51. Sedaghat K, Shen P-J, Bathgate RAD et al. Leucine-rich repeat-containing G-protein-coupled receptor 8 (LGR8) in rat sensorimotor-basal ganglia circuitry. Soc Neurosci Abstr 2006:P450.24.
52. Liu C, Chen J, Sutton S et al. Identification of relaxin-3/INSL7 as a ligand for GPCR142. J Biol Chem 2003; 278:50765-50770.
53. Matsumoto M, Kamohara M, Sugimoto T et al. The novel G-protein coupled receptor SALPR shares sequence similarity with somatostatin and angiotensin receptors. Gene 2000; 248:183-189.
54. Sutton SW, Bonaventure P, Kuei C et al. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: Further support that relaxin-3 is the physiological ligand for GPCR135. Neuroendocrinology 2006; 82:139-150.
55. Liu C, Chen J, Kuei C et al. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Mol Pharmacol 2005; 67:231-240.
56. Sherwood OD. Relaxin's physiological roles and other diverse actions. Endocr Rev 2004; 25:205-234.
57. Gunnersen JM, Crawford RJ, Tregear GW. Expression of the relaxin gene in rat tissues. Mol Cell Endocrinol 1995; 110:55-64.
58. Samuel CS, Tian H, Zhao L et al. Relaxin is a key mediator of prostate growth and male reproductive tract development. Lab Invest 2003; 83:1055-1067.
59. Ivell R, Hartung S. The molecular basis of cryptorchidism. Mol Hum Reprod 2003; 9:175-181.
60. Ferlin A, Simonato M, Bartoloni L et al. The INSL3-LGR8/GREAT ligand-rcceptor pair in human cryptorchidism. J Clin Endocrinol Metab 2003; 88:4273-4279.
61. Roh J, Virtanen H, Kumagai J et al. Lack of LGR8 gene mutation in Finnish patients with a family history of cryptorchidism. Reprod Biomed Online 2003; 7:400-406.
62. Ferlin A, Bogatcheva NV, Gianesello L et al. Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: Clinical and functional characterization. Mol Hum Reprod 2006; 12:401-406.
63. Osheroff PL, Ho W-H. Expression of relaxin mRNA and relaxin receptors in postnatal and adult rat brains and hearts. J Biol Chem 1993; 268:15193-15199.
64. Burazin TCD, Davern P, McKinley MJ et al. Identification of relaxin and relaxin responsive cells in the rat brain. In: Tregear GW, Ivell R, Bathgate RAD, Wade JD, ed. Proceedings of the Third International Conference on Relaxin and Related Peptides. Dordrecht: Kluwer Academic Publishers, 2001:209-214.
65. Ma S, Roozendaal B, Burazin TCD et al. Relaxin receptor activation in the basolateral amygdala impairs memory consolidation. Eur J Neurosci 2005; 22:2117-2122.
66. Allen Institute for Brain Science. Allen Brain Atlas [Website]. Available at: http://www.brain-map.org. Accessed October, 2006.
67. Hokfelt T, Broberger C, Xu ZQ. et al. Neuropeptides - an overview. Neuropharmacology 2000; 39:1337-1356.
68. Ludwig M, Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci 2006; 7:126-136.
69. Tanaka M, Iijima N, Miyamoto Y et al. Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress. Eur J Neurosci 2005; 21:1659-1670.
70. Ma S, Bonaventure P, Ferraro T et al. Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-protein-coupled receptor-135 in the rat. Neuroscience 2007; 144:165-190.
71. Papez J. Comparative Neurology. New York, 1929.
72. Chatfield PO, Lyman CP. An unusual structure in the floor of the fourth ventricle of the golden hamster, Mesocricetus auratus. J Comp Neurol 1954; 101:225-235.
73. Meesen H, Olszewski J. A Cytoarchitectonic Atlas of the Rhombencephalon of the Rabbit. Basel, 1949.
74. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press, 1986.
75. Jennes L, Stumpf WE, Kalivas PW. Neurotensin: Topographical distribution in rat brain by immunohistochemistry J Comp Neurol 1982; 210:211-224.
76. Morest DK. Connexions of the dorsal tegmental nucleus in rat and rabbit. J Anat 1961; 95:229-246.
77. Bittencourt JC, Sawchenko PE. Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system. J Neurosci 2000; 20:1142-1156.
78. Goto M, Swanson LW, Canteras NS. Connections of the nucleus incertus. J Comp Neurol 2001; 438:86-122.
79. Olucha-Bordonau FE, Teruel V, Barcia-Gonzalez J et al. Cytoarchitecture and efferent projections of the nucleus incertus of the rat. J Comp Neurol 2003; 464:62-97.
80. Bathgate RAD, Ivell R, Sanborn BM et al. International Union of Pharmacology LVII: Recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 2006; 58:7-31.
81. Osheroff PL, Phillips HS. Autoradiographic localization of relaxin binding sites in rat brain. Proc Natl Acad Sci USA 1991; 88:6413-6417.
82. Ma S, Shen PJ, Burazin TCD et al. Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) mRNA and [(33)P]-relaxin binding sites in rat brain: Restricted somatic coexpression a clue to relaxin action? Neuroscience 2006; 141:329-344.
83. Sutton SW, Bonaventure P, Kuei C et al. Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing. Neuroendocrinology 2004; 80:298-307.
84. Krajnc-Franken MA, Van Disseldorp AJ, Koenders JE et al. Impaired nipple development and parturition in LGR7 knockout mice. Mol Cell Biol 2004; 24:687-696.
85. Piccenna L, Shen P-J, Ma S et al. Localization of LGR7 gene expression in adult mouse brain using LGR7 knock-out/LacZ knock-in mice: Correlation with LGR7 mRNA distribution. Ann N Y Acad Sci 2005; 1041:197-204.
86. Sinnayah P, Burns P, Wade JD et al. Water drinking in rats resulting from intravenous relaxin and its modification by other dipsogenic factors. Endocrinology 1999; 140:5082-5086.
87. Summerlee AJ, Homsby DJ, Ramsey DG. The dipsogenic effects of rat relaxin: The effect of photoperiod and the potential role of relaxin on drinking in pregnancy. Endocrinology 1998; 139:2322-2328.
88. Gross PM. Circumventricular organ capillaries. Prog Brain Res 1992; 91:219-233.
89. Sunn N, McKinley MJ, Oldfield BJ. Identification of efferent neural pathways from the lamina terminalis activated by blood-borne relaxin. J Neuroendocrinol 2001; 13:432-437.
90. Bathgate RAD, Lin F, Hanson NF et al. Relaxin-3: Improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry 2006; 45:1043-1053.
91. Thornton SM, Fitzsimons JT. The effects of centrally administered porcine relaxin on drinking behaviour in male and female rats. J Neuroendocrinol 1995; 7:165-169.
92. O'Byrne KT, Eltringham L, Summerlee AJ. Central inhibitory effects of relaxin on the milk ejection reflex of the rat depends upon the site of injection into the cerebroventricular system. Brain Res 1987; 405:80-83.
93. Parry LJ, Poterski RS, Summerlee AJ. Effects of relaxin on blood pressure and the release of vasopressin and oxytocin in anesthetized rats during pregnancy and lactation. Biol Reprod 1994; 50:622-628.
94. Heine PA, Di S, Ross LR anderson LL et al. Relaxin-induced expression of Fos in the forebrain of the late pregnant rat. Neuroendocrinology 1997; 66:38-46.
95. McKinley MJ, Burns P, Colvill LM et al. Distribution of Fos immunoreactivity in the lamina terminalis and hypothalamus induced by centrally administered relaxin in conscious rats. J Neuroendocrinol 1997; 9:431-437.
96. Cronin MJ, Malaska T. Characterization of relaxin-stimulated cyclic AMP in cultured rat anterior pituitary cells: Influence of dopamine, somatostatin and gender. J Mol Endocrinol 1989; 3:175-182.
97. McGowan BM, Stanley SA, Smith KL et al. Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 2005; 146:3295-3300.
98. McGowan BM, Stanley SA, Smith KL et al. Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul Pept 2006; 136:72-77.
99. Hida T, Takahashi E, Shikata K et al. Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats. J Recept Signal Transduct Res 2006; 26:147-158.
100. Hwang JJ, Sherwood OD. Monoclonal antibodies specific for rat relaxin. III. Passive immunization with monoclonal antibodies throughout the second half of pregnancy reduces cervical growth and extensibility in intact rats. Endocrinology 1988; 123:2486-2490.
101. Guico-Lamm ML, Sherwood OD. Monoclonal antibodies specific for rat relaxin. II. Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts birth in intact rats. Endocrinology 1988; 123:2479-2485.
102. Kuenzi MJ, Sherwood OD. Monoclonal antibodies specific for rat relaxin. VII. Passive immunization with monoclonal antibodies throughout the second half of pregnancy prevents development of normal mammary nipple morphology and function in rats. Endocrinology 1992; 131:1841-1847.
103. Summerlee AJ, Ramsey DG, Poterski RS. Neutralization of relaxin within the brain affects the timing of birth in rats. Endocrinology 1998; 139:479-484.
104. Zhao L, Roche PJ, Gunnersen JM et al. Mice without a functional relaxin gene are unable to deliver milk to their pups. Endocrinology 1999; 140:445-453.
105. Price JL. Comparative aspects of amygdala connectivity. Ann N Y Acad Sci 2003; 985:50-58.
106. Sah P, Faber ES, Lopez De Armentia M et al. The amygdaloid complex: Anatomy and physiology. Physiol Rev 2003; 83:803-834.
107. Pitkanen A. Connectivity of the rat amygdaloid complex. In: Aggleton JP, ed. The Amygdala: A Functional Analysis. Oxford, UK: Oxford University Press, 2000:31-115.
108. Cardinal RN, Parkinson JA, Hall J et al. Emotion and motivation: The role of the amygdala, ventral striatum and prefrontal cortex. Neurosci Biobehav Rev 2002; 26:321-352.
109. Hamann SB, Ely TD, Grafton ST et al. Amygdala activity related to enhanced memory for pleasant and aversive stimuli. Nat Neurosci 1999; 2:289-293.
110. McGaugh JL, McIntyre CK, Power AE. Amygdala modulation of memory consolidation: Interaction with other brain systems. Neurobiol Learn Mem 2002; 78:539-552.
111. McGaugh JL. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 2004; 27:1-28.
112. Nunez A, Cervera-Ferri A, Olucha-Bordonau F et al. Nucleus incertus contribution to hippocampal theta rhythm generation. Eur J Neurosci 2006; 23:2731-2738.
113. Banerjee A, Ma S, Ortinau S et al. Relaxin-3 neurons in the nucleus incertus: Projection patterns, response to swim stress and RLX3 neuronal signaling. Soc Neurosci Abstr 2005; 35:59.57.
114. Hamann S. Nosing in on the emotional brain. Nat Neurosci 2003; 6:106-108.
115. Schoenbaum G, Chiba AA, Gallagher M. Neural encoding in orbitofrontal cortex and basolateral amygdala during olfactory discrimination learning. J Neurosci 1999; 19:1876-1884.
116. Dielenberg RA, McGregor IS. Defensive behavior in rats towards predatory odors: A review. Neurosci Biobehav Rev 2001; 25:597-609.
117. Levy F, Keller M, Poindron P. Olfactory regulation of maternal behavior in mammals. Horm Behav 2004; 46:284-302.
118. Crawley JN. Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities and specific behavioral tests. Brain Res 1999; 835:18-26.
119. Silvertown JD, Geddes BJ, Summerlee AJ. Adenovirus-mediated expression of human prorelaxin promotes the invasive potential of canine mammary cancer cells. Endocrinology 2003; 144:3683-3691.
120. Bell GI, Pictet RL, Rutter WJ et al. Sequence of the human insulin gene. Nature 1980; 284:26-32.
121. Jansen M, van Schaik FM, Ricker AT et al. Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature 1983; 306:609-611.
122. Bell GI, Merryweather JP, Sanchez-Pescador R et al. Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature 1984; 310:775-777.